Skip to main content
Erschienen in: Wiener klinische Wochenschrift 3-4/2015

01.02.2015 | original article

Invasive Candida infections in patients of a medical intensive care unit

Attempt of improving diagnosis by quantifying the colonization

verfasst von: Sebastian Kautzky, MD, Thomas Staudinger, MD, Elisabeth Presterl, MD

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 3-4/2015

Einloggen, um Zugang zu erhalten

Summary

Background

During the past decades, a steady increase in the incidence of invasive Candida infections in patients requiring intensive care has been reported. Nevertheless, the diagnosis of invasive Candida infections in the intensive care unit setting remains still difficult and is often made late in the course of disease. Additionally, prognosis worsens rapidly with delayed initiation of antifungal therapy. Clinical scoring systems such as the Candida colonization index or the four risk factor-based Candida score could be very useful tools to select patients at high risk of developing invasive Candida infections, who would benefit from the administration of systemic antifungal therapy.

Objectives

The main objective was to determine the incidence of invasive Candida infection among patients of a medical intensive care unit and to investigate its association with the Candida colonization index and the Candida score.

Material and methods

A prospective, observational, single-center study was performed from December 2010 to December 2011. All patients over the age of 18 years who were admitted for at least 7 days in a medical intensive care unit were included. Demographic characteristics, underlying diseases, reasons for intensive care unit admission and presence and duration of risk factors for Candida species colonization and infection were collected for each patient. The Candida colonization index and the Candida score were calculated weekly until discharge or death.

Results

A total of 65 patients were included. Proven invasive Candida infections were diagnosed in five patients (7.7 %), i.e. two developed candidemia, two peritonitis, and one pneumonia. All of these patients were characterized by a Candida colonization index ≥ 0.5 (incidence rate: 16.7 % [5/30]) and a Candida score ≥ 2.5 (incidence rate: 29.4 % [5/17]). Mechanical ventilation (p = 0.013) and both Candida scoring systems (p = 0.013 versus p < 0.001) were statistically and significantly associated with invasive Candida infections. The mortality rate was high (80 %). Interestingly, treatment with antifungal drugs was not statistically and significantly associated with invasive candidiasis (p = 0.077) and patients outcome (p = 0.057).

Conclusion

Both the Candida colonization index and the Candida score with cut-off values ≥ 0.5 and ≥ 2.5 are very useful tools to select patients at high risk of developing invasive Candida infections in the medical intensive care unit setting, who would benefit from early antifungal treatment.
Literatur
1.
Zurück zum Zitat Hollenbach E. Invasive candidiasis in the ICU: evidence based and on the edge of evidence. Mycoses. 2008;51(Suppl 2):25–45.CrossRefPubMed Hollenbach E. Invasive candidiasis in the ICU: evidence based and on the edge of evidence. Mycoses. 2008;51(Suppl 2):25–45.CrossRefPubMed
3.
Zurück zum Zitat Kratzer C, et al. Design and use of Candida scores at the intensive care unit. Mycoses. 2011;54(6):467–74.CrossRefPubMed Kratzer C, et al. Design and use of Candida scores at the intensive care unit. Mycoses. 2011;54(6):467–74.CrossRefPubMed
4.
Zurück zum Zitat Leon C, et al. A bedside scoring system (“Candida score”) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization. Critl Care Med. 2006;34(3):730–7.CrossRef Leon C, et al. A bedside scoring system (“Candida score”) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization. Critl Care Med. 2006;34(3):730–7.CrossRef
5.
Zurück zum Zitat Guery BP, et al. Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part I. Epidemiology and diagnosis. Intensive Care Med. 2009;35(1):55–62.CrossRefPubMed Guery BP, et al. Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part I. Epidemiology and diagnosis. Intensive Care Med. 2009;35(1):55–62.CrossRefPubMed
6.
Zurück zum Zitat Ostrosky-Zeichner L, Pappas PG. Invasive candidiasis in the intensive care unit. Crit Care Med. 2006;34(3):857–63.CrossRefPubMed Ostrosky-Zeichner L, Pappas PG. Invasive candidiasis in the intensive care unit. Crit Care Med. 2006;34(3):857–63.CrossRefPubMed
7.
Zurück zum Zitat Ostrosky-Zeichner L. Invasive mycoses: diagnostic challenges. Am J Med. 2012;125(1 Suppl):S14–24.CrossRef Ostrosky-Zeichner L. Invasive mycoses: diagnostic challenges. Am J Med. 2012;125(1 Suppl):S14–24.CrossRef
8.
Zurück zum Zitat Philip A, et al. Syscan3, a kit for detection of anti-Candida antibodies for diagnosis of invasive candidiasis. J Clin Microbiol. 2005;43(9):4834–5.CrossRefPubMedCentralPubMed Philip A, et al. Syscan3, a kit for detection of anti-Candida antibodies for diagnosis of invasive candidiasis. J Clin Microbiol. 2005;43(9):4834–5.CrossRefPubMedCentralPubMed
9.
Zurück zum Zitat Pappas PG, et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;48(5):503–35.CrossRefPubMed Pappas PG, et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;48(5):503–35.CrossRefPubMed
10.
Zurück zum Zitat Eggimann P, Garbino J, Pittet D. Epidemiology of Candida species infections in critically ill non-immunosuppressed patients. Lancet Infect Dis. 2003;3(11):685–702.CrossRefPubMed Eggimann P, Garbino J, Pittet D. Epidemiology of Candida species infections in critically ill non-immunosuppressed patients. Lancet Infect Dis. 2003;3(11):685–702.CrossRefPubMed
11.
Zurück zum Zitat Blumberg HM, et al. Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey. Clin Infect Dis. 2001;33(2):177–86.CrossRefPubMed Blumberg HM, et al. Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey. Clin Infect Dis. 2001;33(2):177–86.CrossRefPubMed
12.
Zurück zum Zitat Wey SB, et al. Risk factors for hospital-acquired candidemia. A matched case-control study. Arch Intern Med. 1989;149(10):2349–53.CrossRefPubMed Wey SB, et al. Risk factors for hospital-acquired candidemia. A matched case-control study. Arch Intern Med. 1989;149(10):2349–53.CrossRefPubMed
13.
Zurück zum Zitat Ostrosky-Zeichner L. Prophylaxis or preemptive therapy of invasive candidiasis in the intensive care unit? Crit Care Med. 2004;32(12):2552–3.CrossRefPubMed Ostrosky-Zeichner L. Prophylaxis or preemptive therapy of invasive candidiasis in the intensive care unit? Crit Care Med. 2004;32(12):2552–3.CrossRefPubMed
14.
Zurück zum Zitat Charles PE, et al. Candida spp. colonization significance in critically ill medical patients: a prospective study. Intensive Care Med. 2005;31(3):393–400.CrossRefPubMed Charles PE, et al. Candida spp. colonization significance in critically ill medical patients: a prospective study. Intensive Care Med. 2005;31(3):393–400.CrossRefPubMed
16.
Zurück zum Zitat Leon C, et al. Usefulness of the “Candida score” for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: a prospective multicenter study. Crit Care Med. 2009;37(5):1624–33.CrossRefPubMed Leon C, et al. Usefulness of the “Candida score” for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: a prospective multicenter study. Crit Care Med. 2009;37(5):1624–33.CrossRefPubMed
18.
Zurück zum Zitat Vincent JL, et al. Epidemiology, diagnosis and treatment of systemic Candida infection in surgical patients under intensive care. Intensive Care Med. 1998;24(3):206–16.CrossRefPubMed Vincent JL, et al. Epidemiology, diagnosis and treatment of systemic Candida infection in surgical patients under intensive care. Intensive Care Med. 1998;24(3):206–16.CrossRefPubMed
19.
Zurück zum Zitat Marchetti O, et al. Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991–2000. Clin Infect Dis. 2004;38(3):311–20.CrossRefPubMed Marchetti O, et al. Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991–2000. Clin Infect Dis. 2004;38(3):311–20.CrossRefPubMed
20.
Zurück zum Zitat Bassetti M, et al. Candida infections in the intensive care unit: epidemiology, risk factors and therapeutic strategies. Expert Rev Anti Infect Ther. 2006;4(5):875–85.CrossRefPubMed Bassetti M, et al. Candida infections in the intensive care unit: epidemiology, risk factors and therapeutic strategies. Expert Rev Anti Infect Ther. 2006;4(5):875–85.CrossRefPubMed
21.
Zurück zum Zitat Rangel-Frausto MS, et al. National epidemiology of mycoses survey (NEMIS): variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units. Clin Infect Dis. 1999;29(2):253–8.CrossRefPubMed Rangel-Frausto MS, et al. National epidemiology of mycoses survey (NEMIS): variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units. Clin Infect Dis. 1999;29(2):253–8.CrossRefPubMed
22.
Zurück zum Zitat Kullberg BJ, et al. European expert opinion on the management of invasive candidiasis in adults. Clin Microbiol Infect. 2011;17(Suppl 5):1–12.CrossRefPubMed Kullberg BJ, et al. European expert opinion on the management of invasive candidiasis in adults. Clin Microbiol Infect. 2011;17(Suppl 5):1–12.CrossRefPubMed
23.
Zurück zum Zitat Jorda-Marcos R, et al. Risk factors for candidaemia in critically ill patients: a prospective surveillance study. Mycoses. 2007;50(4):302–10.CrossRefPubMed Jorda-Marcos R, et al. Risk factors for candidaemia in critically ill patients: a prospective surveillance study. Mycoses. 2007;50(4):302–10.CrossRefPubMed
24.
Zurück zum Zitat McKinnon PS, et al. Temporal assessment of Candida risk factors in the surgical intensive care unit. Arch Surg. 2001;136(12):1401–8 (discussion 1409).CrossRefPubMed McKinnon PS, et al. Temporal assessment of Candida risk factors in the surgical intensive care unit. Arch Surg. 2001;136(12):1401–8 (discussion 1409).CrossRefPubMed
25.
Zurück zum Zitat Nucci M, Colombo AL. Risk factors for breakthrough candidemia. Eur J Clinl Microbiol Infect Dis. 2002;21(3):209–11.CrossRef Nucci M, Colombo AL. Risk factors for breakthrough candidemia. Eur J Clinl Microbiol Infect Dis. 2002;21(3):209–11.CrossRef
26.
Zurück zum Zitat Piazza O, et al. Candidemia in intensive care patients. Risk factors and mortality. Minerva Anestesiol. 2004;70(1–2):63–9.PubMed Piazza O, et al. Candidemia in intensive care patients. Risk factors and mortality. Minerva Anestesiol. 2004;70(1–2):63–9.PubMed
27.
Zurück zum Zitat Garbino J, et al. Prevention of severe Candida infections in nonneutropenic, high-risk, critically ill patients: a randomized, double-blind, placebo-controlled trial in patients treated by selective digestive decontamination. Intensive Care Med. 2002;28(12):1708–17.CrossRefPubMed Garbino J, et al. Prevention of severe Candida infections in nonneutropenic, high-risk, critically ill patients: a randomized, double-blind, placebo-controlled trial in patients treated by selective digestive decontamination. Intensive Care Med. 2002;28(12):1708–17.CrossRefPubMed
28.
Zurück zum Zitat Pelz RK, et al. Double-blind placebo-controlled trial of fluconazole to prevent candidal infections in critically ill surgical patients. Ann Surg. 2001;233(4):542–8.CrossRefPubMedCentralPubMed Pelz RK, et al. Double-blind placebo-controlled trial of fluconazole to prevent candidal infections in critically ill surgical patients. Ann Surg. 2001;233(4):542–8.CrossRefPubMedCentralPubMed
29.
Zurück zum Zitat Leroy O, et al. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005–2006). Critical Care Med. 2009;37(5):1612–8.CrossRef Leroy O, et al. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005–2006). Critical Care Med. 2009;37(5):1612–8.CrossRef
30.
Zurück zum Zitat Bassetti M, Mikulska M, Viscoli C. Bench-to-bedside review: therapeutic management of invasive candidiasis in the intensive care unit. Crit Care. 2010;14(6):244.CrossRefPubMedCentralPubMed Bassetti M, Mikulska M, Viscoli C. Bench-to-bedside review: therapeutic management of invasive candidiasis in the intensive care unit. Crit Care. 2010;14(6):244.CrossRefPubMedCentralPubMed
31.
Zurück zum Zitat Charles PE, et al. Candidemia in critically ill patients: difference of outcome between medical and surgical patients. Intensive Care Med. 2003;29(12):2162–9.CrossRefPubMed Charles PE, et al. Candidemia in critically ill patients: difference of outcome between medical and surgical patients. Intensive Care Med. 2003;29(12):2162–9.CrossRefPubMed
32.
Zurück zum Zitat Michalopoulos AS, Geroulanos S, Mentzelopoulos SD. Determinants of candidemia and candidemia-related death in cardiothoracic ICU patients. Chest. 2003;124(6):2244–55.CrossRefPubMed Michalopoulos AS, Geroulanos S, Mentzelopoulos SD. Determinants of candidemia and candidemia-related death in cardiothoracic ICU patients. Chest. 2003;124(6):2244–55.CrossRefPubMed
33.
Zurück zum Zitat Viale P. Candida colonization and candiduria in critically ill patients in the intensive care unit. Drugs. 2009;69(Suppl 1):51–7.CrossRefPubMed Viale P. Candida colonization and candiduria in critically ill patients in the intensive care unit. Drugs. 2009;69(Suppl 1):51–7.CrossRefPubMed
34.
Zurück zum Zitat Dimopoulos G, et al. Candida albicans versus non-albicans intensive care unit-acquired bloodstream infections: differences in risk factors and outcome. Anesth Analg. 2008;106(2):523–9 (table of contents).CrossRefPubMed Dimopoulos G, et al. Candida albicans versus non-albicans intensive care unit-acquired bloodstream infections: differences in risk factors and outcome. Anesth Analg. 2008;106(2):523–9 (table of contents).CrossRefPubMed
35.
Zurück zum Zitat Dubau B, Triboulet C, Winnock S. [Use of the colonization index]. Ann Fr Anesth Reanim. 2001;20(4):418–20.CrossRefPubMed Dubau B, Triboulet C, Winnock S. [Use of the colonization index]. Ann Fr Anesth Reanim. 2001;20(4):418–20.CrossRefPubMed
36.
Zurück zum Zitat Chabasse D. [Yeast count in urine. Review of the literature and preliminary results of a multicenter prospective study carried out in 15 hospital centers]. Ann Fr Anesth Reanim. 2001;20(4):400–6.CrossRefPubMed Chabasse D. [Yeast count in urine. Review of the literature and preliminary results of a multicenter prospective study carried out in 15 hospital centers]. Ann Fr Anesth Reanim. 2001;20(4):400–6.CrossRefPubMed
37.
Zurück zum Zitat Piarroux R, et al. Assessment of preemptive treatment to prevent severe candidiasis in critically ill surgical patients. Crit Care Med. 2004;32(12):2443–9.CrossRefPubMed Piarroux R, et al. Assessment of preemptive treatment to prevent severe candidiasis in critically ill surgical patients. Crit Care Med. 2004;32(12):2443–9.CrossRefPubMed
38.
Zurück zum Zitat Normand S, et al. Oral nystatin prophylaxis of Candida spp. colonization in ventilated critically ill patients. Intensive Care Med. 2005;31(11):1508–13.CrossRefPubMed Normand S, et al. Oral nystatin prophylaxis of Candida spp. colonization in ventilated critically ill patients. Intensive Care Med. 2005;31(11):1508–13.CrossRefPubMed
39.
Zurück zum Zitat Agvald-Ohman C, et al. Invasive candidiasis in long-term patients at a multidisciplinary intensive care unit: Candida colonization index, risk factors, treatment and outcome. Scand J Infect Dis. 2008;40(2):145–53.CrossRefPubMed Agvald-Ohman C, et al. Invasive candidiasis in long-term patients at a multidisciplinary intensive care unit: Candida colonization index, risk factors, treatment and outcome. Scand J Infect Dis. 2008;40(2):145–53.CrossRefPubMed
40.
Zurück zum Zitat Senn L, et al. Caspofungin for prevention of intra-abdominal candidiasis in high-risk surgical patients. Intensive Care Med. 2009;35(5):903–8.CrossRefPubMed Senn L, et al. Caspofungin for prevention of intra-abdominal candidiasis in high-risk surgical patients. Intensive Care Med. 2009;35(5):903–8.CrossRefPubMed
41.
Zurück zum Zitat Eggimann P, Ostrosky-Zeichner L. Early antifungal intervention strategies in ICU patients. Current Opin Crit Care. 2010;16(5):465–9.CrossRef Eggimann P, Ostrosky-Zeichner L. Early antifungal intervention strategies in ICU patients. Current Opin Crit Care. 2010;16(5):465–9.CrossRef
43.
Zurück zum Zitat Wang DH, et al. [The preemptive treatment of invasive Candida infection with reference of corrected colonization index in critically ill patients: a multicenter, prospective, randomized controlled clinical study]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2009;21(9):525–8.PubMed Wang DH, et al. [The preemptive treatment of invasive Candida infection with reference of corrected colonization index in critically ill patients: a multicenter, prospective, randomized controlled clinical study]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2009;21(9):525–8.PubMed
44.
Zurück zum Zitat Leroy G, et al. Evaluation of “Candida score” in critically ill patients: a prospective, multicenter, observational, cohort study. Ann Intensive Care. 2011;1(1):50.CrossRefPubMedCentralPubMed Leroy G, et al. Evaluation of “Candida score” in critically ill patients: a prospective, multicenter, observational, cohort study. Ann Intensive Care. 2011;1(1):50.CrossRefPubMedCentralPubMed
45.
Zurück zum Zitat Charles PE, et al. Serum procalcitonin levels in critically ill patients colonized with Candida spp: new clues for the early recognition of invasive candidiasis? Intensive Care Med. 2009;35(12):2146–50.CrossRefPubMed Charles PE, et al. Serum procalcitonin levels in critically ill patients colonized with Candida spp: new clues for the early recognition of invasive candidiasis? Intensive Care Med. 2009;35(12):2146–50.CrossRefPubMed
46.
Zurück zum Zitat Posteraro B, et al. Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1→3)-beta-d-glucan assay, Candida score, and colonization index. Crit Care. 2011;15(5):R249.CrossRefPubMedCentralPubMed Posteraro B, et al. Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1→3)-beta-d-glucan assay, Candida score, and colonization index. Crit Care. 2011;15(5):R249.CrossRefPubMedCentralPubMed
47.
Zurück zum Zitat Eggimann P, Marchetti O. Is (1→3)-beta-d-glucan the missing link from bedside assessment to pre-emptive therapy of invasive candidiasis? Crit Care. 2011;15(6):1017.CrossRefPubMedCentralPubMed Eggimann P, Marchetti O. Is (1→3)-beta-d-glucan the missing link from bedside assessment to pre-emptive therapy of invasive candidiasis? Crit Care. 2011;15(6):1017.CrossRefPubMedCentralPubMed
48.
Zurück zum Zitat Horn DL, et al. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. Clin Infect Dis, 2009;48(12):1695–703.CrossRefPubMed Horn DL, et al. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. Clin Infect Dis, 2009;48(12):1695–703.CrossRefPubMed
50.
Zurück zum Zitat Hsueh PR, et al. Consensus statement on the management of invasive candidiasis in intensive care units in the Asia-Pacific Region. Int J Antimicrob Agents. 2009;34(3):205–9.CrossRefPubMed Hsueh PR, et al. Consensus statement on the management of invasive candidiasis in intensive care units in the Asia-Pacific Region. Int J Antimicrob Agents. 2009;34(3):205–9.CrossRefPubMed
51.
Zurück zum Zitat Gudlaugsson O, et al. Attributable mortality of nosocomial candidemia, revisited. Clin Infect Dis. 2003;37(9):1172–7.CrossRefPubMed Gudlaugsson O, et al. Attributable mortality of nosocomial candidemia, revisited. Clin Infect Dis. 2003;37(9):1172–7.CrossRefPubMed
52.
Zurück zum Zitat Pagano L, et al. The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. Haematologica. 2006;91(8):1068–75.PubMed Pagano L, et al. The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. Haematologica. 2006;91(8):1068–75.PubMed
53.
Zurück zum Zitat Colombo AL, et al. Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers. J Clin Microbiol. 2006;44(8):2816–23.CrossRefPubMedCentralPubMed Colombo AL, et al. Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers. J Clin Microbiol. 2006;44(8):2816–23.CrossRefPubMedCentralPubMed
Metadaten
Titel
Invasive Candida infections in patients of a medical intensive care unit
Attempt of improving diagnosis by quantifying the colonization
verfasst von
Sebastian Kautzky, MD
Thomas Staudinger, MD
Elisabeth Presterl, MD
Publikationsdatum
01.02.2015
Verlag
Springer Vienna
Erschienen in
Wiener klinische Wochenschrift / Ausgabe 3-4/2015
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI
https://doi.org/10.1007/s00508-014-0644-z

Weitere Artikel der Ausgabe 3-4/2015

Wiener klinische Wochenschrift 3-4/2015 Zur Ausgabe

MUW researcher of the month

Researcher of the month